Fluid Retention Syndrome in Women by Al-Jadir, Saad J.S.
Fluid Retention Syndrome in Women 
Saadi .1.S AL Jadir 

College of Medicine, Babylon University 

Abstract 
The term "FRS" is more accu­
rate than the commonly used term 
"idiopathic edema" as it embodies 
the view that the condition has multi 
factorial aetiolgy. FRS of women 
may defined as fluid retention occur­
ring in the absence of well - defined 
hydrostatic or oncotic mechanism as 
a result of congestive cardiac failure, 
hypoproteinema or local venous or 
lymphatic obstruction. 
FRS may result from humoral, 
metabolic, autonomic and iatrogenic 
mechanisms. The syndrome com­
prises a triad of fluid retention, au­
tonomic disturbance and affective 
disorder, the latter froms the inte­
gral aspect of the syndrome and the 
condition is a true psychosomatic 
disorder. 
The symptoms of fluid reten­
tion are varible and many patients 
are subjected to multiple hospitel 
refrrals for unnecessary investiga­
tions, medication or surgery which 
can be avioded once the unitarv na­
." 
ture of the syndome is well appre­
ciated. 
From November 1991- Nov. 
1994 we could study 52 cases of typ­
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ical triad symptoms of FRS between 
the age of 16-52 years (mean 36.5 
years). 
Those cases repesent oure ongo­
ing workup to find out more cases to 
establish the syndrome as atTue entity 
in our current medical practice. 
Introduction 
Fluid retention syndrome in 
women (FRS) 
The commonly used term for 
FRS "Idiopatic edema" is misleading, 
because sufferers rarely show pitting 
or. dependent edema and contributo­
ry risk factors can be defined, the 
descriptive trem "FRS" is more ac­
curate as it embodies the view that 
the condition has multi factorial ae­
tiology. 
In the mind of many doctore 
: "FRS" exists as nebulous entity asso­
ciated with women who demand diu­
retic for "bloating" or " swelling". 
The condition is frequently, 
confused with premenstrual tension 
and some deny its existence dismiss­
ing as imaginary the complaints of 
women who insist that they swell 
during the day have to spend the 
evening in loose dressings(l). 
Definition 
"FRS" may be defined as a fluid 
retention in the absence of well de­
fined hydrorstatic or oncotic mech­
nism as result of congestive cardiac 
failure, hypoproteinemia or local ve­
nous or lymphatic obstruction. 
Most patients are between 20-50 
years but the onset may follow men­
opause. it is rare in children, al­
though the syndrome was found be­
tween 2-10 years of age where there 
is strong family history of the syn­
drome. The FRS is extremelv rere in 
males(1). • 
Aetiology 
FRS may result frome humoral, 
metabolic, autonomic and iatrogeinc 
mechanisms(2) . 
Although the aetiology is uncer­
tain, increased permeability of capil­
lary walls accentuated by arteriolar 
vasodilation appears to be a primary 
causal factor(3,4), both mechanisms 
result in the transfer of fluid from 
the vascular to the extra vascular 
compartment with the resulting hy­
povolemia leading to sodium and 
water retention through Renin­
Angiotensin-Aldosterone system. 
Clinical Features of FRS 
These comprise a triad of 
symptoms of fluid retention ,func­
tional autonomtic disturbance, and 
affective psychiatric disorder(2). The 
second and the third components of 
the triad are persent to a variable de­
gree in the individual pations. 
Fluid retention leads to com­
plaints of swelling of the face, hands, 
breasts, abdment and legs, which be­
come worse as the day advances. The 
patient frequently changes into loose 
clothes, and the hour at which this 
occurs is a useful measure of the se­
verity of the disorder. The patients's 
face may appear puffy and bolated, 
rings may be discarded and a dis­
tended abdomen may lead to aCcusa­
tions of pregnancy. 
Most women retain fluid to 
some extent, during premenstrual 
period, and there is no clear dividing 
line between normal and abnormal 
fluid retention. Fluid retention is 
usally accompanied by diuranal 
weight gain of between 1.4 and 6.0 
Kg(3-14 1b) daily. A diurnal weight 
variation of more that 1.4 daily is 
abnormal(5). Longer term fluc~ua­
tions weight with a periodicity of 1­
2 weeks are not uncommon. 
Parasympathetic overactivity 
That includes hyperactivity of 
the bowel, bladder and vascular sys­
tem, a history of irritable bowel; 
with complaint of abdominal pain, 
intermittent diarrhea and constipa­
tion is common and the patients my 
be referred to gastroentrologist or 
gynecologist. 
Complaints of urge frequency 
of micturition amonuting to urge in­
contience and in severe cases may 
lead to unnecessary antibiotics treat­
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ment for urinary "infection" or re­
ferral to a urologist. 
Intermittent vasovagal attacks 
are not uncommon and lead to a mis­
taken diagnosis of epilepsy and neu­
rological referral. 
Most fluid retention patients ex­
hibit symptoms of varying degree of 
affective disorder, these range from 
minor degree of fatigue, irriitability, 
anxiety and depression. Affective 
symptoms frome an integral part of 
FRS and the condition is a true psyo­
hosomatic disorder(6) . 
Visual. blurring caused by reti­
nal edema is common in fluid retain­
ing patients; and lead to consult the 
Ophthalmologist. 
Tension headaches commonly 
accompany affective symptoms, in 
few patients headaches is severe and 
worse in the morning resembling 
headache of increased intracranial 
pressure, presumbly caused by a de­
'-'
gree of cerbral edema. 
Polydipsia result from hypovo­
lemic stimulus following extravas­
tion of fluid from intravasscular to 
extravascular compartment leads to 
consumpiton of large quantities of 
fluid with nocturnal polyuria.!f 
thirst is intense the patient may be 
suspected of having diabetes mellitus 
or hysterical water drinking. 
In summary the symptoms of 
FRS are variable and many patients 
are subjected to multiple hospital re­
ferrals for unnecessary investiga­
tions, medications or surgery which 
can be avoided once the scope of the 
syndrome is appreciated. 
Risk factors for FRS 
Recognition of the contributory 
risk factors in fuluid retention is es­
sential for rational management. 
Metabolic Factors 
Obesity or .a historyo.f weight 
gain is found in most fluid-retainig 
patients. A family history of diabetes 
is common, and acute fluid retention 
may occure in the both sexes with 
the instilution of insulin therapy for 
diabetes mellitus (,insulin oedma,)(7) 
Subacute and chronic froms of dia­
betic oedema are seen in young 
women with unstable diabetes(8). 
Endocrine Factors 
Thyrotoxicosis, hypothroi­
dism (9) and estrogens may be asso­
ciated with fluid retention. More 
subtle endocrine disturbances may be 
involved in the aetiology of fluid re­
tention. 
In one study, urinary dopamine 
levels were low in patients with fluid 
retention (10) and, in another, gona­
dotrophin level were raised after 
stimulation with releasing hormones 
compared with control patients(1l). 
Rsychiatric Factors 
Affective symptoms are com 
1110n in fluid-retaining patients and 
onset may follow emotional stress 
444 
related to life-events. 
Iatrogenic Factors 
Drugs may precipitate fulid­
retaining symptoms in predisposed 
patients. 
Short-tern1 Precipitants 
Prologed standing, high ambi­
ent tempertures, a febrile illness and 
acute emotional stress, liberal die­
tary intake (Alcohol, high carbohy­
rate diet) may accentuate pre­
existing fluid retention [Table 1]. 
Hypotheical Links between 
the Risk Factors and the 
Fluid Retention Syndrolne 
The nature of the endocrine or 
metabolic defect responsible for ab­
nom1al fulid retention in women is 
unknown. Increased sympathetic ac­
tivity may diminish renal sodium 
and water excretion via diminshed 
renal dopamine synthesis(10). Active 
neurogenic vasodilation with in 
creased bowel and bladder contrac­
tility leading to fluid retention, the 
irritable bowel syndrome and urge 
frequency of micturition may have a 
common basis; increased parasympa­
thetic (cholinergic) activity. In fluid­
retaining patients, increased auto­
nomic activity appeares to be driven 
centrally via the connections of the 
hypothalamus with limbic system; 
the putative site of affective disor­
der. 
The association of fluid reten­
tion with obesity, diabetes mellitus 
or a diabetic family history may re­
sult from the absoute or relative 
hyerinsulinaemia that commonly ac­
companies these metablic disorders. 
Insulin is Known to induce renal re­
tention of solium and water, and in­
sulin-mediated upregulation of cellu­
lar sodium/potassium ATPase results 
in efflux of sodium from the intra­
cellular compartment and fall in in­
tracellular sodium and calcium that 
will lead to fall in ressistance vessel 
resulting in arteriolar vasodilation 
increases capillary ultrafiltration and 
augments fluid retention via arterial 
hypovolemia. As in type- II diabetes 
mellitus, insulin responsiveness may 
be restored by dietary restriction, 
leading to effective weight loss. 
The mechanisms of vasodilating 
precipitants of fluid retention (such 
as thyrotoxicosis, fever and high am­
bient temperature) and of iatrogenic 
precipitants such a estrogens, dana­
zol and NSAID's are well recong­
nized and require little com­
ment(12,13). 
Management of the Fluid 
Retention Syndrome 
It is important to reach an accu­
rate diagnosis of the condition based 
on the exclusion of cardiac, hypo­
proteinaemic and obstructive cases 
of oedema. this may be achieved by 
appropriate screening investigations, 
a characteristic history and the dem­
onstration of the abnormal diurnal 
weight variation by means of weight 
chart kept by the patient over a peri­
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od of 2-4 weeks. Most cases respond 
to removal or modification of the 
contributory risk factores listed ear­
lier.[Table 2]. 
Weight-reactive Fluid Reten­
tion 
Where fluid retetion is wieght­
reactive, the important aspect of 
management is to retunl the patient 
to a traget weight. This may be de­
fined either as the patient's weight in 
early adult life or, less ambitiousuly, 
body weight prior to the onset of 
fluid retention. It is important to set 
realistic goals for weight reduction. 
Long-term weight loss of 0.5-1.5 Kg 
(1-2 lb) weekly is satisfactory but 
losses of up to 2.3-2.7 Kg (5-6 Ib) 
may occur in the first weeks of diet­
ing as a result of fluid loss. Salt re­
~triction is unnecessary beyond that 
Imposed by reduced caloric intake. 
fluid intake should not be restricted. 
Symptoms of bloating and 
swelling subside, accompanying af­
fectve symptoms improve, and in 
many cases, the patient describes a 
sense of well-being and positive 
health that may have been absent for 
many years. In most cases of weiaht­
reactive fluid retention, die~lfY 
means are sufficient to control 
symptoms, diuretics are usually un­
necessary and not be prescribed ini­
tally. 
Psychiartic Fluid Retention 
A proportion of non obese ful­
id-retaining patients give no historv 
of weight gain before the onset o"'f 
syptoms. In these patients, the domi­
nant risk factors are usuallv emo­
tional, and diuretics are effe~tive in 
controlling symptoms in inverse 
proportion to the degree of psychiat­
ric abnonnality present. 
Symptoms of autonomic hye­
ractivity often improve with treat­
ment of fluid-retaining symptoms bv 
dietary means. Severe syptoms of th~ 
irritable bowel or urge frequencv of 
micturition may requite the pre­
scription of an anticholinergic drug. 
In patients with severe urae frequen­
. b 
cyand mcontinece of micturition, a 
referral to a urologist for urody­
namic studies and bladder retraining 
may be necessary. Affective symp­
toms often improve with the treat­
ment of fulid retention, but patients 
with severe anxiety and deression re­
main unwell and may require psv­
chiatric referral. . 
Iatrogenic fluid Retention 
This ceases when the offending 
drug is stopped. Fluid retention re­
lated to thyroid disoder responds to 
specific treatment. Diabetic oedema 
is best managed by dietary measures 
to achieve ideal weight and the estab­
lishment of optimal metablic control' 
diuretics may be required in som~ 
cases. 
Role of Diuretice 
The place of diuretics in the 
management of fluid retention is 
controversiaL On one hand, the only 
treatment many patients receive is a 
diuretic prescribed by general prac­
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titioner for 'bloating', while on the 
other, it has been claimed that fluid 
retention is diuretic induces ill­
ness(15). 
According to the author's ex­
perience, fluid-retaining symptoms 
have invariably preceded the pre­
scription of a diuretic; women are 
recultant to take diuretics and anx­
ious to stop them. However, it is 
possible that diuretic abuse (like lax­
ative abuse) is seen in a few patients 
referred to specialist centers. 
Diuretics are most effective in 
non obese fluid retaining women 
with no history of weight gain or se­
vere affective illness. 
As weight increases or psychiat­
ric illness becomes more severe, 
they become less effective. This may 
lead to the consumption of increas­
ing doses of diuretic (especially loop 
diuretics) with the consequent risk of 
electrolyte depletion. Diuretics are 
usually inffective in obese fluid­
retaining patients or in patients with 
severe psychiatric disorder regard­
less of weight. 
A thiazide diuretic with either a 
potassium supplement or potassium 
sparing diuretic should be prescribed 
if required. Loop diuretics should be 
avoided and spironolatone is no 
longer recommended for the treat­
ment of fluid retention sydrome. 
Many women find that diuretics 
are required only intermittently to 
control exacerbation of fluid reten­
tion related to the risk factors de­
scibed above. If these removed or 
subside spontaneously, diuretics may 
be gradually reduced and discontin­
ued. However, patients who discon­
tinue diuretics should be warned that 
withdrawal my be followed bv 1-2 
weeks of self-limiting rebound ~ede­
rna. 
Role of Other Drugs 
Several o-trier drugs have been 
used in the management of the fluid 
retention in small numbers of pa­
tients. These include bromocriptine, 
levodopa, dexamphetamine, pro­
pranolol, captopril and chlorpropa­
mide. In the author view, these 
drugs have no place in the manage­
ment of most patients with fluid re­
tention their use should be restricted 
to patients with refractory fluid re­
tention syndrome referred to : spe­
cialized centers(1). 
Prognosis of the fluid reten­
tion syndrolne 
The results of managing most 
patients with weight-reactive fluid 
retention are good provided that the 
patient complies with dietary advice 
and attains target weight. Relapses 
inevitably occur as a result of die­
tary indiscretions when the fluid­
retaining symptoms return. These 
can be controlled by returning to a 
strict diet and optimum weight. 
The prognosis for relief of 
symptoms is not as good for slim pa­
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tients with severe affective symtoms 
related to neurotic or depressive ill­
ness or to continuing social stress, or 
for patients who cannot loose 
weight. Even in these patients, sup­
port and explanation of the nature of 
the illness is therapeutic, enabling 
the patient to understand and cope 
with previoualy in comprehensible 
symptoms. The management of this 
common condition deserves more at­
tention and knowledge of the unitary 
of the syndrome. 
Research and Discussion 
I have started conducting this 
work for the first time in our coun­
try willing for the future fluid reten­
tion clinic to enrich the pool of cases 
referral. 
From autumn 1991 to novem­
ber 1994 I could register 52 women 
of typical triad symptoms of the syn­
drome, between the age of 16 to 52 
years mean age (36.5 years) and for 
ethical purposes I asked our regis­
trars in the medical unit in Merjan 
hospital for case reporting in special 
printed formula. 
We have met a lot of technical, 
laboratory and economic difficulties 
and lack of endocrine assay because 
of the present situation of our coun­
try due to imposed sanction, but we 
could overcome those problems by 
extensive medical efforts, utilizing 
the available facilities coupled with 
intensive follow up of cases. 
We have study those cases by 
screening then with the appropriate 
investigations to exclude other causes 
of oedema. We informed the patients 
to have weight chart (2-4 weeks), 
but for economical reasons we have 
received only 20 weight charts that 
eventually showed the diurnal varia­
tion in body weight. 
We could not register children 
cases although pediaricians have 
mentioned undefined oedema in a 
few children. Strong family history 
of the syndrome could be got in 
most of the patients. History of dia­
betes mellitus and diabetic family 
and thyroid disease were present in 
significant number of cases (24,14) 
respectively and in (14) multiple en­
docrine disorders (Diabetes mellitus, 
thyroid disease, menstrual disorders 
... ) could be observed. Over weight 
was found in most patients and psy­
chiatric patients with ideal body 
weight was detected in lesser number 
of cases. 
We will continue our ongoing 
work up to find out more cases to 
establish the syndrome as true entity 
in our current medical practice. 
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Table 1 Major risk factors for the FRS 

Female sex 
Metabolic factors 
- Obesity (20% over ideal weight­
reactive fluid retention). 
- Weight gain with in the normal 
weight range for age height 
(weight reactive fluid reten­
tion). 
- Diabetic family history. 
- Diabetes mellitus (diabetic oede­
ma) 
Endocrine factol's. 
- Oestrogens (premenstrual fluid 
retention). 
Thyroxine (hypo-and hyperthyr­
oidism). 
Psychiatric factors 
- Reactive/ endogenous depres­
SIOn. 
-Anxiety states-depression 
Iatoreenic factors 
- Steroid honnones (oestrogens as 
oral contracepives or as hor­
mone-replacement therapy, 
fludrocortisone, danazol). 
- Aldosterone-like compounds 
carbenoxolone, liquorice) 
- NSAID's (including aspirin). 
Hypotensive druge 
(guanethidine, hydralazine, 
prazosin, calcium channel an­
tagonists). 
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Table 2 Management of the FRS 

EstabHsh an accurate dia~· 
nosis 
-Ask the patient to complete 
twic-daily weight chart for 2­
4 weeks. 
- Exclude cardiac, hypoprotei­
naemic and obstmctive causes 
of oedema 
Explain: 

- the nature of the symptoms. 

- the risk factors. 

- the short ten11 precipitants of 
fluid retention. 
- Withdraw offending dmgs. 

Advise 

- A reduced calorie intake. 

- A realistic rate of weidt loss. 
- A target weight for weight re­
active fluid retention (do not 
prescribe diuretics) 
Prescribe a diuretic if indi­
cated Cnotspironolactone) 
- A thiazide plus a potassium sup­
plament, or. 
A thiazide plus a potassium­
sparing diuretic. 
Treat associated autonomic 
symptoms 
Refer patients 
affectivs illness 
trist. 
with 
to a 
severe 
psychia­
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